Literature DB >> 4946100

A clinical trial of an antiserotonin compound, cinanserin, in chronic schizophrenia.

J M Holden, A Keskiner, P Gannon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4946100

Source DB:  PubMed          Journal:  J Clin Pharmacol New Drugs        ISSN： 0021-9754


× No keyword cloud information.
  2 in total

1.  Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.

Authors:  Lili Chen; Chunshan Gui; Xiaomin Luo; Qingang Yang; Stephan Günther; Elke Scandella; Christian Drosten; Donglu Bai; Xichang He; Burkhard Ludewig; Jing Chen; Haibin Luo; Yiming Yang; Yifu Yang; Jianping Zou; Volker Thiel; Kaixian Chen; Jianhua Shen; Xu Shen; Hualiang Jiang
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms.

Authors:  Emily G Severance; Faith B Dickerson; Raphael P Viscidi; Ioannis Bossis; Cassie R Stallings; Andrea E Origoni; Anne Sullens; Robert H Yolken
Journal:  Schizophr Bull       Date:  2009-06-02       Impact factor: 9.306
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.